Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension

Overview of attention for article published in BMC Neurology, May 2017

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 27,875 followers.

RT @Dysautonomia: Droxidopa (Northera in the US) is a drug approved for treatment of neurogenic orthostatic hypotension (nOH) that... https…

Droxidopa (Northera in the US) is a drug approved for treatment of neurogenic orthostatic hypotension (nOH) that... https://t.co/oW6Q2Fclz3

Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension https://t.co/4IPGJq5CwU #POTS @VUMChealth

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.